Eurobio-Scientific SA (E8TN) Stock Statistics & Valuation Metrics
Total Valuation
Eurobio-Scientific SA has a market cap or net worth of EUR 258.39M. The enterprise value is EUR 203.86M.
- Market Cap
- EUR 258.39M
- Enterprise Value
- EUR 203.86M
Share Statistics
Eurobio-Scientific SA has 10,068,279 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,068,279
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Eurobio-Scientific SA’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 4.48%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 4.48%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 381.49K
- Profits Per Employee
- 10.98K
- Employee Count
- 443
- Asset Turnover
- 0.66
- Inventory Turnover
- 3.51
Valuation Ratios
The current PE Ratio of Eurobio-Scientific SA is 37.57. Eurobio-Scientific SA’s PEG ratio is 0.18.
- PE Ratio
- 37.57
- PS Ratio
- 1.54
- PB Ratio
- 1.43
- Price to FCF
- 52.46
- Price to Operating Cash Flow
- 13.70
- PEG Ratio
- 0.18
Income Statement
In the last 12 months, Eurobio-Scientific SA had revenue of 169.00M and earned 4.87M in profits. Earnings per share was 0.47.
- Revenue
- 169.00M
- Gross Profit
- 68.40M
- Operating Income
- 15.45M
- Pretax Income
- 7.80M
- Net Income
- 4.87M
- EBITDA
- 32.39M
- Earnings Per Share (EPS)
- 0.47
Cash Flow
In the last 12 months, operating cash flow was 19.67M and capital expenditures -14.62M, giving a free cash flow of 5.05M billion.
- Operating Cash Flow
- 19.67M
- Free Cash Flow
- 5.05M
- Free Cash Flow per Share
- 0.49
Dividends & Yields
Eurobio-Scientific SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.91%
- Earnings Yield
- 2.68%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- 5.50%
- 50-Day Moving Average
- 22.67
- 200-Day Moving Average
- 22.31
- Relative Strength Index (RSI)
- 58.61
- Average Volume (3m)
- 781
Important Dates
Eurobio-Scientific SA upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Apr 10, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Eurobio-Scientific SA as a current ratio of 1.98, with Debt / Equity ratio of 8.71%
- Current Ratio
- 1.98
- Quick Ratio
- 1.36
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.13
- Interest Coverage Ratio
- 7.73
Taxes
In the past 12 months, Eurobio-Scientific SA has paid 2.94M in taxes.
- Income Tax
- 2.94M
- Effective Tax Rate
- 0.38
Enterprise Valuation
Eurobio-Scientific SA EV to EBITDA ratio is 7.22, with an EV/FCF ratio of 50.24.
- EV to Sales
- 1.47
- EV to EBITDA
- 7.22
- EV to Free Cash Flow
- 50.24
- EV to Operating Cash Flow
- 12.89
Balance Sheet
Eurobio-Scientific SA has EUR 26.34M in cash and marketable securities with EUR 14.74M in debt, giving a net cash position of EUR 11.60M billion.
- Cash & Marketable Securities
- EUR 26.34M
- Total Debt
- EUR 14.74M
- Net Cash
- EUR 11.60M
- Net Cash Per Share
- EUR 1.15
- Tangible Book Value Per Share
- -EUR 9.77
Margins
Gross margin is 43.86%, with operating margin of 10.67%, and net profit margin of 4.21%.
- Gross Margin
- 43.86%
- Operating Margin
- 10.67%
- Pretax Margin
- 6.51%
- Net Profit Margin
- 4.21%
- EBITDA Margin
- 20.43%
- EBIT Margin
- 10.67%
Analyst Forecast
The average price target for Eurobio-Scientific SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.28%
- EPS Growth Forecast
- 204.56%